Clinical data and machine learning can help to predict intradialytic hypotension (IDH) for patients undergoing hemodialysis, according to a study published online Sept. 14 in the Journal of Kidney ...

"I was working full-time, running my three kids around at school… I ran businesses," she said. That all came to a head in ...

For patients with symptomatic and severe tricuspid regurgitation (TR), tricuspid transcatheter edge-to-edge repair (T-TEER) ...

The following is a summary of “Echocardiographic Assessment of Cardiac Remodeling According to Obesity Class,” published in the November 2024 issue of Cardiology by Prajapati et al. Obesity is linked ...

For patients with symptomatic and severe or greater tricuspid regurgitation (TR), transcatheter tricuspid valve replacement ...

Transcatheter tricuspid-valve replacement is superior to medical therapy alone for patients with severe tricuspid ...

Edwards Lifesciences Corp., Orange County’s most valuable publicly traded medical device maker, reported third quarter sales ...

If you invested in Edwards Lifesciences, you are encouraged to obtain additional information by visiting .

Although Parore are plentiful in the warmer coastal waters of New Zealand’s upper North Island it is not usually targeted by ...

Investors learned the truth on July 24, 2024, when Edwards Lifesciences announced its Q2 2024 financial results. Among other things, the company revealed that its TAVR sales grew just 5% and slashed ...

TRAVEL II study aims to evaluate the long-term safety and efficacy of LuX-Valve Plus in the application on patients with severe tricuspid regurgitation (TR) and high surgical risk. The clinical trial ...